Company Satsuma Pharmaceuticals, Inc.
Equities
STSA
US80405P1075
Biotechnology & Medical Research
Business Summary
Number of employees: 25
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08/23/08 |
Mic Iwashima
COO | Chief Operating Officer | 46 | 01/17/01 |
Chief Tech/Sci/R&D Officer | 63 | 01/17/01 | |
Shannon Strom
LAW | General Counsel | 48 | 01/18/01 |
Corporate Officer/Principal | - | 05/20/05 | |
Robert Schultz
PRN | Corporate Officer/Principal | 60 | 01/17/01 |
Shinji Nitanda
SEC | Corporate Secretary | 55 | 08/23/08 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08/23/08 |
Director/Board Member | 64 | 08/23/08 | |
Ken Takanashi
BRD | Director/Board Member | 60 | 01/16/01 |
Shunji Haruta
BRD | Director/Board Member | - | 08/23/08 |
Akihisa Mori
BRD | Director/Board Member | - | 08/23/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 33,152,498 | 27,782,705 ( 83.80 %) | 0 | 83.80 % |
Company contact information
Satsuma Pharmaceuticals, Inc.
4819 Emperor Boulevard Suite 340
27703, Durham
+650 410 3200
http://www.satsumarx.comSector
1st Jan change | Capi. | |
---|---|---|
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |